Gene Therapy: The Next-Generation Therapeutics and Their Delivery Approaches for Neurological Disorders
Neurological conditions like neurodevelopmental disorders and neurodegenerative diseases are quite complex and often exceedingly difficult for patients. Most of these conditions are due to a mutation in a critical gene. There is no cure for the majority of these neurological conditions and the avail...
Main Authors: | Abhik Paul, Michael G. Collins, Hye Young Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Genome Editing |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgeed.2022.899209/full |
Similar Items
-
CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
by: Deepak Kumar Sahel, et al.
Published: (2023-07-01) -
Hot topics in cellular neuropathology III: using CRISPR/Cas9 technology for deciphering central nervous system disease targets
by: Dirk M. Hermann
Published: (2023-09-01) -
Harnessing the Potential of CRISPR/Cas in Atherosclerosis: Disease Modeling and Therapeutic Applications
by: Wei Sheng Siew, et al.
Published: (2021-08-01) -
CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics
by: Shanu Bhardwaj, et al.
Published: (2022-09-01) -
Homology-Directed-Repair-Based Genome Editing in HSPCs for the Treatment of Inborn Errors of Immunity and Blood Disorders
by: Daniel Allen, et al.
Published: (2023-04-01)